Walleye Capital LLC
Institutional investor · Portfolio as of Q1 2019
Top Holdings1,467 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ABBVIE INC | 46,200 | $3.7M | 0.6% | — | — | — | New — |
AT&T INC | 106,400 | $3.3M | 0.5% | — | — | — | New — |
MERCK & CO. INC. | 38,200 | $3.2M | 0.5% | — | — | — | Increased — |
TRADE DESK INC/THE -CLASS A | 15,500 | $3.1M | 0.5% | — | — | — | New — |
TORTOISE ACQUISITION CORP | 300,000 | $3M | 0.5% | — | — | 1 qtr | New 44 |
ORACLE CORP | 53,500 | $2.9M | 0.5% | — | — | — | New — |
REGENERON PHARMACEUTICALS | 6,500 | $2.7M | 0.4% | — | — | — | New — |
ESTEE LAUDER COMPANIES-CL A | 16,000 | $2.6M | 0.4% | — | — | — | New — |
COUPA SOFTWARE INC | 28,700 | $2.6M | 0.4% | — | — | — | New — |
THERMO FISHER SCIENTIFIC INC | 9,300 | $2.5M | 0.4% | — | — | — | New — |
8I ENTERPRISES ACQUISITIN CO | 250,000 | $2.5M | 0.4% | — | — | 1 qtr | New 43 |
REVVITY INC | 26,000 | $2.5M | 0.4% | — | — | — | New — |
FEDEX CORP | 13,800 | $2.5M | 0.4% | — | — | — | New — |
CHECK POINT SOFTWARE TECH | 19,700 | $2.5M | 0.4% | — | — | — | New — |
MONGODB INC | 16,900 | $2.5M | 0.4% | — | — | — | New — |
ANI PHARMACEUTICALS INC | 34,800 | $2.5M | 0.4% | — | — | — | New — |
SEMPRA ENERGY | 19,500 | $2.5M | 0.4% | — | — | — | New — |
INCYTE CORP | 27,900 | $2.4M | 0.4% | — | — | — | New — |
GILEAD SCIENCES INC | 36,800 | $2.4M | 0.4% | — | — | — | New — |
AUTODESK INC | 15,100 | $2.4M | 0.4% | — | — | — | New — |
Walleye Capital LLC manages $607.2M across 1467 positions as of Q1 2019. Top holdings: ABBV (0.6%), T (0.5%), MRK (0.5%). Fund DNA: Diversified Scout. HoldingsIntel Rating: 3.5/5.0.
Active quarter - 329 new positions, 255 exits, 4 increased. Top move: SHLL/U (NEW, conviction 44). Portfolio: $607M across 1467 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer